Indian Overseas Bank & BigShare both have a history of big flop IPOs of SMEs , even bigger than karvy. Listed at even upto 20 % discount . Eg : Alpa Lab , Anu Pharma , Astec Life , finotex chem , Idea ( issue price :75 , before 5 years.Now also trading at 75 ) , Omkar Special Chemicals ( Special because despite of huge rally in chemical stocks recently , we have not seen in this 2 chemical stocks.finotex above).
List is infinite . All Stocks can''t be discussed here . Better to visit Bigshare (smallshare) website and have a glance on all IPO stocks.
Better to wait and watch as there are many good IPOs including pharma companies in the 2016 Pipeline.
Today , PNB fund unblocking day . It seems everyone shall be allotted 1 lot each.
Here are some concerns: 1)Company has only 1 product in its portfolio I.e TB vaccine(bcg vaccine) 2)on Dec 2015 UNICEF has awarded contracts for supplying bcg vaccines to 4 suppliers for 3 years, one among them is this company. That''s one of the main reason for boost in profits and revenues.
3) their order book is hardly 12 Cr for fy17 . And they have contracts with UNICEF for 3 years what after that ? That too UNICEF has many suppliers who are supplying about 137mill doses every year this company was given contact to supply just 1mil doses per year. And according to UNICEF forecast the need for this vaccine till 2020 is fulfilled from existing suppliers and no need for extra.
4) they have great margins of about 25â„… but, look at the revenues..! Company with hardly 20cr revenue is asking for a market cap of 300cr ..! That''s ridiculous.
5) company is not getting any money from this issues, promoters are having a nice exit from this company by pulling out 100crs.. look at this, they have started a company 10 years back and started producing vaccines and once they got some UNICEF contract on Dec hardly worth 10cr for 1 years they made valuation of about 300cr and selling uncertain business to people like us.
It''s your money people, for long term investors it''s a STRICT NO..!! There are lot of good companies out there. Don''t fall for the existing balancesheets,look at the fundamentals.
Just to be correction to your point1/ There are actually 2 products offered by Green signal Bio pharma. a./ for BCG vaccine b./ For urinary cancer ( there was contract with Cadila healthcare ltd) but ended in jun,2016. ---------- Further information:-.
But yes, 70-80% revenue is from BCG vaccine and major is from domestic market. From last year they have started exporting.
- Green signal is the 7th largest producer of BCG vaccine in world and 2nd largest in India (after serum institute)
Investing in this IPO is worthy only if population keep on growing at current rate in the world and no new BCG vaccine manufacturer comes in with less expensive option. Also existing vaccine makers don''t increase their volumes.
Septa sir Where will we get secondary market views
Its not about making money from ur call. precisely ur analysis and firmness. V have ample example.like pcl & varun..pcl didn''t go ur way still u r holdind tight till now.in varun no gmp no kostak...still u speak ur mind..sir would u please change ur mind & kindly post abt secondary script view..
https://www.iob.in/uploads/CEDocuments/GSBPL%20RHP.pdf Reading the RHP on page 42 total outstanding shares 38,36,72,750 which is WRONG That is total outstanding capital Total Outstanding SHARES is 3,83,67,275 SHARES is the correct number
However nowhere in RHP the dates of the issue or the price have been mention
Retail quota is only 10% of app. 14,57,956 equity shares @ RS.80. AMOUNT WISE IT COMES TO ONLY RS.11.66 CRORES. NOW EVERYONE CAN GUESS THE POSITION / PROBABILITY OF ALLOTEMENTS. IT WILL BE APPROXIMATE 1:30.
16. Pokemongo| Link| Bookmark|
November 2, 2016 7:20:18 PM
Top Contributor (400+ Posts, 300+ Likes)
this company is dependent on very few products.. that will be a risk..
without knowing the issue price i cannot share my view however at Rs 80 one can apply however this a very small company it more like a SME so risk is high with regards to corporate governance .
Also the issue is very small less then 9000 people will get allotment so it will be real draw of luck
Green signal bio pharma Ltd ka IPO bharna chahiye please help me please advise grey market bhav kitna he Mene rphp Pura download Kiya isme puri deatel he isme company ne growth hi Kiya he aur ye company divided kitna degi please advise
If the price band is right 80 will give MC OF 308 giving aPE of 60 on 2015 books 1st quarter it report a NP of 2.93 Cr if we annualised this we get 11.72 Cr NP GIVE PE OF 26.
Based on this I find vaule in IPO HOWEVER THE IPO IS VERY SMALL
Vishnu, can you ask moderator to open a separate page for secondary market then? couldnt understand why few people discourage valuable contributors like Septa despite not doing any meaning full contribution by themselves. Again you cover up saying you are follower of Septa.. seems like you dont want anyone else to get benefitted.
8. Septa| Link| Bookmark|
November 2, 2016 7:38:34 AM
(4000+ Posts, 4600+ Likes)
Coerce on grey market will only start once they issue get traction from the market sSince it is T group listing not much GMP and kostak will prevail.